Results 271 to 280 of about 291,142 (306)
Some of the next articles are maybe not open access.

Sensitive neutralization test for virus antibody

Archives of Virology, 1978
A sensitive mumps virus plaque neutralization test has been developed based on the potentiation of virus-antibody complexes by heterologous anti-immunoglobulins (AIG). The enhanced neutralization test was approximately 100 times more sensitive than the conventional neutralization test or the hemagglutination-inhibition test.
H, Sato   +4 more
openaire   +2 more sources

Neutralization of Arenaviruses by Antibody

1987
Neutralization of infectivity is the end result of a number of alternative or synergistic reactions between a virus and antibody directed against certain antigenic determinants on its surface. These reactions prevent either the attachment of virus to a particular host cell by steric hindrance, the entry of virus into the cell, or the uncoating of the ...
openaire   +2 more sources

Standardization of Poliovirus Neutralizing Antibody Tests

Clinical Infectious Diseases, 1984
Recently the Forum for Advancement of Immunization Research sponsored a Collaborative Study on Poliovirus Antibody Titration. Twenty laboratories from 12 countries participated. There were considerable differences in detail of test performance and test results among laboratories.
P, Albrecht   +3 more
openaire   +2 more sources

Cytokine-neutralizing therapeutic antibodies

2000
Monoclonal antibodies (Mabs) offer the potential as useful therapeutic agents because of their high affinity and selectivity for the target antigen. The standard approach in making Mabs has been to immunise rodents, usually mice, with the desired human protein and generate a mouse anti-human IgG through hybridoma technology.
Amanda Suitters, Roly Foulkes
openaire   +1 more source

COVID-19-neutralizing antibodies predict disease severity and survival

Cell, 2021
Evan C Lam, Diane Yang, Tyler E Miller
exaly  

HIV-Specific Neutralizing Antibodies

2001
Infection with human immunodeficiency virus type 1 (HIV-1) generates cellular and humoral immune responses of various magnitudes to multiple virus-specific antigens. Perhaps the most beneficial B cell response is one that is directed against the surface gp120 and transmembrane gp41 envelope glycoproteins of the virus; both glycoproteins are major ...
openaire   +1 more source

Home - About - Disclaimer - Privacy